FemTech Capital Joins Women’s Health Innovation Symposium at ETH Zurich
October 28, 2026 | ETH Zurich, Switzerland & Online
FemTech Capital Founder & CEO Alexandra Hirzel will join the Women’s Health Innovation Symposium: From Evidence to Investment, hosted by Nucleate Switzerland at ETH Zurich on October 28.
Alexandra will participate in the panel discussion “Venture Creation & Innovation in Women’s Health,” alongside Lan Zuo Gillet (TECH4EVA), Sanjana Rao, PhD (MIYARA), Cinzia Donato (Hera Biotech), and Lisa Falco (N23 Health).
The symposium brings together investors, entrepreneurs, clinicians, researchers and pharmaceutical industry leaders to address two critical challenges in women’s health: gaps in clinical evidence and barriers to investment.
The discussion will explore how promising scientific and technological advances can translate into viable healthcare ventures, attract capital and ultimately improve patient outcomes.
Why this matters to FemTech Capital
Closing the women’s health gap requires more than scientific breakthroughs. It requires credible clinical evidence, commercially viable innovation, specialist expertise and capital.
At FemTech Capital, we work to connect these elements and advance innovation across women’s health, sex-specific medicine and longevity.
We look forward to contributing to this important conversation and connecting with fellow innovators, investors and healthcare leaders.
Event details
Date: Wednesday, October 28, 2026
Location: ETH Zurich, Switzerland & Livestream
Organizer: Nucleate Switzerland
Advancing the Future of Women’s Health.
FemTech Capital | Science. Capital. Impact.